Skip to content
  • Home
  • Need
  • Solution
    • Anagrelide
  • Team
    • Harri Sihto, Ph.D.
    • Olli-Pekka Pulkka, M.Sc.
    • Olli Kallioniemi, M.D., Ph.D.
    • Pekka Simula, M.Sc.
  • News
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram

Sartar Therapeutics – Novel targeted therapy for GIST

  • Home
  • Need
  • Solution
    • Anagrelide
  • Team
    • Harri Sihto, Ph.D.
    • Olli-Pekka Pulkka, M.Sc.
    • Olli Kallioniemi, M.D., Ph.D.
    • Pekka Simula, M.Sc.
  • News

Sartar in Business Finland pitching competition in HealthBIO Partnering day, May 16

May 10, 2019August 27, 2019 by ollipulkka

https://www.turunmessukeskus.fi/en/event/life-science-live/

Related

Post navigation

Previous Entry:Sartar was chosen to Kasvu Open – Future Health and Wellbeing program

Contact

Sartar Therapeutics Ltd.
Haartman Institute, room C311.1
Haartmaninkatu 3
FI-00290 Helsinki
Finland
info@sartartherapeutics.com

Y-tunnus: 2754654-8
Haartmaninkatu 3

Search

Create a website or blog at WordPress.com
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram